Bio-Rad Laboratories, Inc. (BIO) PEG Ratio: 0.18
Is Bio-Rad Laboratories, Inc.’s PEG ratio high or low?
Bio-Rad Laboratories, Inc.'s PEG ratio of 0.18 is 32% above its 5-year average of 0.14, around the middle of its 5-year range (0.02–0.46).
The PEG ratio for Bio-Rad Laboratories, Inc. (BIO) is 0.18. It is above its 12-month average by 80.00% (0.10).
BIO PEG Ratio Chart
BIO Average PEG Ratio Chart
BIO Current vs Average PEG Ratio Chart
BIO PEG Ratio Metrics
PEG RATIO
0.18
PEG RATIO AVG TTM
0.10
PEG RATIO AVG 3Y
0.17
PEG RATIO AVG 5Y
0.14
PEG RATIO AVG 10Y
0.62
PEG RATIO AVG 15Y
0.59
PEG RATIO AVG 20Y
0.73
CURRENT VS TTM AVG
+80.00%
CURRENT VS 3Y AVG
+2.86%
CURRENT VS 5Y AVG
+31.71%
CURRENT VS 10Y AVG
-71.17%
CURRENT VS 15Y AVG
-69.54%
CURRENT VS 20Y AVG
-75.34%
BIO Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | — | 0.18 | 0.10 | 0.17 | 0.14 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | N/A | 0.04 | 0.51 | 2.58 |
| Hims & Hers Health, Inc. (HIMS) | $6.42B | N/A | 0.83 | 0.68 | 0.68 |
| Baxter International Inc. (BAX) | $10.49B | N/A | 0.18 | 0.70 | 1.43 |
| Align Technology, Inc. (ALGN) | $12.56B | 51.80 | 51.80 | 26.80 | 17.90 |
| Hologic, Inc. (HOLX) | $16.97B | 0.30 | 0.30 | 0.22 | 1.95 |
| Moderna, Inc. (MRNA) | $18.40B | N/A | 0.18 | 0.14 | 0.14 |
| BioNTech SE (BNTX) | $21.81B | N/A | 0.23 | 0.12 | 0.12 |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 8.96 | 5.67 | 4.53 | 3.90 |
| Waters Corporation (WAT) | $23.83B | 75.62 | 75.62 | 40.78 | 27.51 |
Growth-Adjusted Valuation
PEG Ratio
0.18
P/E Ratio
48.1
Bio-Rad Laboratories, Inc. PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. PEG Ratio FAQ
- What is the PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The PEG ratio for BIO stock is 0.18.
- Is Bio-Rad Laboratories, Inc.'s PEG ratio high or low?
- Bio-Rad Laboratories, Inc.'s PEG ratio of 0.18 is 32% above its 5-year average of 0.14, around the middle of its 5-year range (0.02–0.46).
- What is the TTM average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average PEG ratio for BIO stock is 0.10.
- What is the 3Y average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average PEG ratio for BIO stock is 0.17.
- What is the 5Y average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average PEG ratio for BIO stock is 0.14.
- What is the 10Y average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average PEG ratio for BIO stock is 0.62.
- What is the 15Y average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average PEG ratio for BIO stock is 0.59.
- What is the 20Y average PEG ratio for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average PEG ratio for BIO stock is 0.73.
Bio-Rad Laboratories, Inc. PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2023-12-31 | 0.18 |
| 2022-12-31 | 0.02 |
| 2021-12-31 | 0.46 |
| 2020-12-31 | 0.04 |
| 2019-12-31 | 0.02 |
| 2018-12-31 | 0.10 |
| 2017-12-31 | 0.17 |
| 2015-12-31 | 1.67 |
| 2014-12-31 | 2.96 |
| 2010-12-31 | 0.58 |
| 2009-12-31 | 0.30 |
| 2006-12-31 | 0.84 |
| 2005-12-31 | 1.15 |
| 2003-12-31 | 1.73 |
| 2002-12-31 | 0.28 |
| 2001-12-31 | 0.43 |
| 2000-12-31 | 0.08 |
| 1998-12-31 | 0.22 |
| 1996-12-31 | 3.63 |
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz